Creating a blood test for herpes simplex viruses 1 and 2.
Official title: SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
Funded at Kephera Diagnostics, LLC · NIH-11203290 · Data updated 2026-11-12
This study is working on a new blood test that can help find out if someone has been infected with the herpes virus, so that people can get better treatment and support for their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kephera Diagnostics, LLC NIH-funded |
| Lab location | 1 site (Framingham, UNITED STATES) |
| Project start | September 10, 2024 |
| Project end | September 9, 2025 |
| Funding year | 2024 |
| Award (this year) | $300,000 |
| NIH project number | 75N93024C00045-0-9999-1 |
| Project ID | NIH-11203290 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who suspect they may have been infected with herpes simplex viruses 1 or 2.
✕Less likely to help
Patients who have already been diagnosed and are receiving effective treatment for herpes simplex infections may not benefit from this research.
What this research studies
This research focuses on developing a serological test that can accurately detect infections caused by Herpes Simplex Virus types 1 and 2. The approach involves creating a diagnostic tool that can identify antibodies in the blood, which indicates whether a person has been infected with these viruses. By improving the accuracy and availability of testing, this research aims to enhance the diagnosis and management of herpes infections, ultimately benefiting patients through better-informed treatment options.
Why it matters
Potential benefit: If successful, this research could provide a reliable and accessible blood test for diagnosing herpes simplex infections, leading to improved patient care.
How similar studies have gone: Other research has shown success in developing serological tests for viral infections, indicating that this approach has potential for success.
Where this research is happening
-
Kephera Diagnostics, LLC
Framingham, United States Active
Researchers
- Principal investigator: Levin, Andrew — Kephera Diagnostics, LLC
- Study coordinator: Levin, Andrew
Related research
Other NIH-funded projects on the same topics.
-
Peptide-based Diagnostic Test for Sarcoidosis
A new test using peptide-based ELISA is being developed to diagnose sarcoidosis, potentially reducing the need for invasive lung biopsies.
-
Rapid bedside test for neurocysticercosis in adults with seizures
A quick clinic test to detect brain tapeworm infection (neurocysticercosis) in adults who present with seizures.
-
Finding new ways to diagnose neglected tropical diseases.
This study is looking for new ways to quickly and accurately diagnose neglected tropical diseases caused by a parasite called T. cruzi, so that patients can get the right treatment sooner.
-
Rapid diagnostic test for Strongyloides infection
A quick, easy-to-use test is being developed to detect Strongyloides infections, helping people who may have returned from at-risk areas or who are immunocompromised.
-
Single-step, more accurate blood test for Lyme disease
This project is creating a single-step blood test that is easier to use and less likely to give false positives so people get faster, clearer Lyme diagnoses.
-
Biomarker test to confirm cure from Chagas disease
A blood-based biomarker test to tell people treated for Chagas disease whether the infection is cured.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.